XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Series A Preferred Stock
Preferred Stock
Common Stock
Additional Paid-In-Capital
Dividends in Excess of Earnings
Total
Balances at beginning of period at Dec. 31, 2022 $ 14,009 $ 28 $ 2,065,248 $ (117,392) $ 1,961,893
Balances at beginning of period (in shares) at Dec. 31, 2022   27,972,830      
Net Income (Loss)       82,361 82,361
Issuance of unvested restricted stock, net of forfeitures     (568)   (568)
Issuance of unvested restricted stock, net of forfeitures (in shares)   35,024      
Exchange of Exchangeable Senior Notes     1,964   1,964
Exchange of Exchangeable Senior Notes (in shares)   32,200      
Preferred stock dividend       (676) (676)
Common stock dividend       (101,467) (101,467)
Stock-based compensation     9,713   9,713
Balances at end of period at Jun. 30, 2023 14,009 $ 28 2,076,357 (137,174) 1,953,220
Balances at end of period (in shares) at Jun. 30, 2023   28,040,054      
Balances at beginning of period at Mar. 31, 2023 14,009 $ 28 2,071,473 (127,363) 1,958,147
Balances at beginning of period (in shares) at Mar. 31, 2023   28,034,999      
Net Income (Loss)       41,269 41,269
Issuance of unvested restricted stock, net of forfeitures (in shares)   5,055      
Preferred stock dividend       (338) (338)
Common stock dividend       (50,742) (50,742)
Stock-based compensation     4,884   4,884
Balances at end of period at Jun. 30, 2023 14,009 $ 28 2,076,357 (137,174) 1,953,220
Balances at end of period (in shares) at Jun. 30, 2023   28,040,054      
Balances at beginning of period at Dec. 31, 2023 14,009 $ 28 2,095,789 (156,854) 1,952,972
Balances at beginning of period (in shares) at Dec. 31, 2023   28,140,891      
Balances at end of period at Mar. 31, 2024 14,009 $ 28 2,111,111 (169,721) 1,955,427
Balances at end of period (in shares) at Mar. 31, 2024   28,328,647      
Balances at beginning of period at Dec. 31, 2023 14,009 $ 28 2,095,789 (156,854) 1,952,972
Balances at beginning of period (in shares) at Dec. 31, 2023   28,140,891      
Net Income (Loss)       81,421 81,421
Issuance of unvested restricted stock, net of forfeitures     (750)   (750)
Issuance of unvested restricted stock, net of forfeitures (in shares)   39,310      
Exchange of Exchangeable Senior Notes (in shares)   28,408      
Net proceeds from sale of common stock     11,757   11,757
Net proceeds from sale of common stock (in shares)   123,224      
Preferred stock dividend       (676) (676)
Common stock dividend       (106,210) (106,210)
Stock-based compensation     8,686   8,686
Balances at end of period at Jun. 30, 2024 14,009 $ 28 2,115,482 (182,319) 1,947,200
Balances at end of period (in shares) at Jun. 30, 2024   28,331,833      
Balances at beginning of period at Mar. 31, 2024 14,009 $ 28 2,111,111 (169,721) 1,955,427
Balances at beginning of period (in shares) at Mar. 31, 2024   28,328,647      
Net Income (Loss)       41,993 41,993
Issuance of unvested restricted stock, net of forfeitures (in shares)   3,186      
Preferred stock dividend       (338) (338)
Common stock dividend       (54,253) (54,253)
Stock-based compensation     4,371   4,371
Balances at end of period at Jun. 30, 2024 $ 14,009 $ 28 $ 2,115,482 $ (182,319) $ 1,947,200
Balances at end of period (in shares) at Jun. 30, 2024   28,331,833